Case Study: Mega Lifesciences achieves 360° marketing visibility and driver-based budgeting with Board

Marketing Planning and Analysis at Mega Lifesciences

Mega Lifesciences, a Thailand‑based pharmaceutical and health‑wellness group operating in 30+ countries, faced fragmented marketing budgeting and planning processes: different countries used Excel or legacy tools, qualitative brand strategies weren’t linked to numbers, and prior standardization efforts failed due to poor offline support and limited planning capabilities. The company needed a unified, intuitive Enterprise Performance Management approach that combined budgeting, strategy and analytics while working reliably in low‑connectivity environments.

Mega selected the Board Decision‑Making Platform and is rolling it out in three phases: flexible, template‑driven budgeting (brand/SKU/quantity/value); driver‑based strategy management to tie qualitative plans to forecasts; and advanced marketing analytics for 360° visibility. After a successful proof of concept, the implementation—now underway—has already standardized processes, increased planning flexibility and is expected to deliver faster, more informed marketing decisions by combining quantitative and strategic insights on a single platform.

Mega Lifesciences

Arun Singh

Chief Information Officer